ADOCIA announces its participation in key events.
6:00 p.m. CET – Adocia (Euronext Paris: FR0011184241 – ADOC), a clinical-stage biopharmaceutical company specializing in the research and development of innovative therapeutic solutions for the treatment of diabetes and obesity, today announces the participation of its management team at the following conferences:
• 36th Annual Roth Conference – March 17-19, Dana Point, California, USA
This event offers investors the opportunity to listen to and meet executives from approximately 500 private and public companies.
• Bio-Europe Spring – March 18-20, Barcelona, Spain
This important partnering event brings together more than 2,000 companies for individual meetings.
• Congress of the Francophone Diabetes Society – March 19-22, Toulouse, France
This event covers all aspects of modern diabetology from fundamentals to clinical practice, reserving a large place for therapeutic, technological innovations and e-health.
• Investor Access – April 4-5, Paris, France
This event, dedicated to individual shareholders, brings together companies and investors for conferences and individual meetings.